Bermúdez-Bejarano
EB, Serrera-Figallo MA, Gutiérrez-Corrales A,
Romero-Ruiz MM, Castillo-de-Oyagüe R, Gutiérrez-Pérez
JL, Torres-Lagares D. Prophylaxis and antibiotic therapy in management
protocols of patients treated with oral and intravenous bisphosphonates. J Clin Exp Dent. 2017;9(1):e141-9.
doi:10.4317/jced.53372
References
|
1. French Health Products
Safety Agency (Afssaps). Prescribing antibiotics in
odontology and stomatology.
Recommendations by the French Health Products Safety Agency. Fundam Clin Pharmacol.
2003;17:725-9. |
|
|
|
|
|
2. Peterson LJ. Antibiotic
prophylaxis against wound infections in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1990;48:617-20. PMid:2341942 |
|
|
|
|
|
3. Tong DC, Rothwell BR. Antibiotic prophylaxis in dentistry: a
review and practice recommendations. J Am Dent Assoc. 2000;131:366-74. |
|
|
|
|
|
4. Carmona IT, Diz Dios P, Scully C. An update on the controversies in
bacterial endocarditis of oral origin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:660-70. |
|
|
|
|
|
5. Shrout
MK, Scarbrough F, Powell BJ. Dental care and the
prosthetic joint patient: a survey of orthopedic surgeons and general
dentists. J Am Dent Assoc. 1994;125:429-36. |
|
|
|
|
|
6.
Gutiérrez JL, Bagán JV, Bascones
A, Llamas R, Llena J, Morales A, Noguerol B, Planells P, Prieto J, Salmerón JI. Consensus document on the use of antibiotic
prophylaxis in dental surgery and procedures. Med Oral Patol
Oral Cir Bucal. 2006;11:E188-205. |
|
|
|
|
|
7. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-7. PMid:12966493 |
|
|
|
|
|
8. Marx RE, Sawatari Y, Fortin M, Broumand
V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of
the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005;63:1567-75. |
|
|
|
|
|
9.
Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates:
a review of 63 cases. J
Oral Maxillofac Surg.
2004;62:527-34. |
|
|
|
|
|
10.
Leizaola-Cardesa IO, Aguilar-Salvatierra A, Gonzalez-Jaranay M, Moreu G,
Sala-Romero MJ, Gómez-Moreno G. Bisphosphonates, vitamin D, parathyroid hormone,
and osteonecrosis of the jaw. Could there be
a missing link? Med Oral Patol Oral Cir Bucal. 2016;21:e236-40. |
|
|
|
|
|
11.
Ponte Fernández N, Estefania Fresco R, Aguirre Urizar JM. Bisphosphonates and oral
pathology I. General and preventive aspects. Med Oral Patol
Oral Cir Bucal. 2006;11:E396-400. |
|
|
|
|
|
12.
Bagán J, Blade J, Cozar JM, Constela M, García Sanz R, Gómez Veiga F, et al. Recommendations
for the prevention, diagnosis, and treatment of osteonecrosis
of the jaw (ONJ) in cancer patients treated with bisphosphonates.
Med Oral Patol
Oral Cir Bucal. 2007;12:E336-40. |
|
|
|
|
|
13.
Campisi G, Di Fede O, Musciotto A, Lo Casto A, Lo Muzio
L, Fulfaro F, et al. Bisphosphonate-related osteonecrosis of the jaw (BRMRONJ):
run dental management designs and issues in diagnosis. Ann Oncol. 2007 Jun;18 Suppl 6:vi168-72. |
|
|
|
|
|
14. Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A. Tooth extraction in patients taking
intravenous bisphosphonates: a preventive protocol
and case series. J
Oral Maxillofac Surg. 2010;68:107-10. |
|
|
|
|
|
15. Saia G, Blandamura S, Bettini G, Tronchet A, Totola A, Bedogni G, et al. Occurrence of bisphosphonate-related
osteonecrosis of the jaw after surgical tooth
extraction. J Oral Maxillofac Surg. 2010;68:797-804. |
|
|
|
|
|
16. Scoletta
M, Arduino PG, Pol R, Arata V, Silvestri S, Chiecchio A, Mozzati M. Initial
experience on the outcome of teeth extractions in intravenous bisphosphonate-treated patients: a cautionary report. J Oral Maxillofac Surg. 2011;69:456-62. |
|
|
|
|
|
17. Ferlito
S, Puzzo S, Liardo C.
Preventive protocol for tooth extractions in patients treated with zoledronate: a case series. J Oral Maxillofac Surg. 2011;69:e1-4. |
|
|
|
|
|
18.
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of Oral and Maxillofacial
Surgeons. American Association of Oral and Maxillofacial Surgeons position
paper on medication-relatedosteonecrosis of the
jaw--2014 update. J Oral Maxillofac Surg. 2014;
72(10):1938-56. Mozzati M, Gallesio
G, Arata V, Pol R, Scoletta M. Platelet-rich therapies in the treatment of
intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol. 2012 May;48(5):469-74. |
|
|
|
|
|
19. Kato GF, Lopes RN,
Jaguar GC, Silva AP, Alves FA. Evaluation of socket
healing in patients undergoing bisphosphonate
therapy: experience of a single Institution. Med Oral Patol
Oral Cir Bucal. 2013;18:e650-6. |
|
|
|
|
|
20.
Vescovi P, Giovannacci I,
Merigo E, Meleti M, Manfredi M, Fornaini C, et al. Tooth extractions in high-risk patients under bisphosphonate therapy and previously affected with osteonecrosis of the jaws: surgical protocol supported by
low-level laser therapy. J Craniofac Surg. 2015;26:696-9. |
|
|
|
|
|
21. Alons
K, Kuijpers SC, de Jong
E, van Merkesteyn JP. Treating low- and
medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment
of chronic suppurative osteomyelitis:
report of 7 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:e1-7. |
|
|
|
|
|
22. Stanton DC, Balasanian E. Outcome of surgical management of bisphosphonate-related osteonecrosis
of the jaws: review of 33 surgical cases. J Oral Maxillofac
Surg. 2009;67:943-50. |
|
|
|
|
|
23. Ferlito
S, Puzzo S, Palermo F, Verzì
P. Treatment of bisphosphonate-related osteonecrosis of the jaws: presentation of a protocol and
an observational longitudinal study of an Italian series of cases. Br J Oral Maxillofac Surg. 2012;50:425-9. |
|
|
|
|
|
24. Williamson RA.
Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int
J Oral Maxillofac Surg. 2010;39:251-5. |
|
|
|
|
|
25. Eckardt
AM, Lemound J, Lindhorst D, Rana M, Gellrich NC. Surgical management of bisphosphonate-related
osteonecrosis of the jaw in oncologic patients: a
challenging problem. Anticancer Res. 2011;31:2313-8. PMid:21737657 |
|
|
|
|
|
26. Vescovi
P, Merigo E, Meleti M, Manfredi M, Guidotti R, Nammour S. Bisphosphonates-related
osteonecrosis of the jaws: a concise review of the
literature and a report of a single-centre experience with 151 patients. J
Oral Pathol Med. 2012;41:214-21. |
|
|
|
|
|
27. Eckert AW, Maurer P,
Meyer L, Kriwalsky MS, Rohrberg
R, Schneider D, et al. Bisphosphonate-related jaw
necrosis-severe complication in maxillofacial surgery. Cancer Treat Rev. 2007
Feb;33(1):58-63. |
|
|
|
|
|
28.
Junquera L, Gallego L, Cuesta P, Pelaz A, de
Vicente JC. Clinical experiences with bisphosphonate-associated
osteonecrosis of the jaws: analysis of 21 cases. Am
J Otolaryngol. 2009;30:390-5. |
|
|
|
|
|
29. Epstein MS, Wicknick FW, Epstein JB, Berenson JR, Gorsky
M. Management of bisphosphonate-associated osteonecrosis: pentoxifylline
and tocopherol in addition to antimicrobial
therapy. An initial case series. Oral Surg Oral Med
Oral Pathol Oral Radiol Endod. 2010;110:593-6. |
|
|
|
|
|
30. Van den Wyngaert T, Claeys T, Huizing MT, Vermorken JB, Fossion E. Initial experience with conservative treatment
in cancer patients with osteonecrosis of the jaw
(ONJ) and predictors of outcome. Ann Oncol.
2009;20:331-6. |
|
|
|
|
|
31. Saussez
S, Javadian R, Hupin C, Magremanne M, Chantrain G, Loeb
I, et al. Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors:
a Belgian case series. Laryngoscope. 2009;119:323-9. |
|
|
|
|
|
32. Hoefert
S, Eufinger H. Relevance of a prolonged
preoperative antibiotic regime in the treatment of bisphosphonate-related
osteonecrosis of the jaw. J Oral Maxillofac Surg. 2011;69:362-80. |
|
|
|
|
|
33. Vidal-Real C, Pérez-Sayáns M, Suárez-Peñaranda
JM, Gándara-Rey JM, García-García
A. Osteonecrosis of the jaws in 194 patients who
have undergone intravenous bisphosphonate therapy
in Spain. Med Oral Patol Oral Cir Bucal. 2015;20:e267-72. |
|
34. Gavaldá C, Bagán JV. Concept, diagnosis and
classification of bisphosphonate-associated osteonecrosis of the jaws. A
review of the literature. Med Oral Patol
Oral Cir Bucal. 2016;21:e260-70.
https://doi.org/10.4317/medoral.21001
PMid:26827066 PMCid:PMC4867198